Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 75, Issue 3, Pages 237-256Publisher
WILEY
DOI: 10.1111/j.1747-0285.2009.00940.x
Keywords
-
Funding
- National Science Foundation [CC044917]
- National Institutes of Health [NLM108730, 1R21GM087617-01]
- Pennsylvania Department of Health
Ask authors/readers for more resources
Membrane proteins pose problems for the application of NMR-based ligand-screening methods because of the need to maintain the proteins in a membrane mimetic environment such as detergent micelles: they add to the molecular weight of the protein, increase the viscosity of the solution, interact with ligands non-specifically, overlap with protein signals, modulate protein dynamics and conformational exchange and compromise sensitivity by adding highly intense background signals. In this article, we discuss the special considerations arising from these problems when conducting NMR-based ligand-binding studies with membrane proteins. While the use of C-13 and N-15 isotopes is becoming increasingly feasible, F-19 and H-1 NMR-based approaches are currently the most widely explored. By using suitable NMR parameter selection schemes independent of or exploiting the presence of detergent, H-1-based approaches require least effort in sample preparation because of the high sensitivity and natural abundance of H-1 in both, ligand and protein. On the other hand, the F-19 nucleus provides an ideal NMR probe because of its similarly high sensitivity to that of H-1 and the lack of natural F-19 background in biologic systems. Despite its potential, the use of NMR spectroscopy is highly underdeveloped in the area of drug discovery for membrane proteins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available